Riganti_2005_Br.J.Pharmacol_146_1096

Reference

Title : Long-term exposure to the new nicotinic antagonist 1,2-bisN-cytisinylethane upregulates nicotinic receptor subtypes of SH-SY5Y human neuroblastoma cells - Riganti_2005_Br.J.Pharmacol_146_1096
Author(s) : Riganti L , Matteoni C , Di Angelantonio S , Nistri A , Gaimarri A , Sparatore F , Canu-Boido C , Clementi F , Gotti C
Ref : British Journal of Pharmacology , 146 :1096 , 2005
Abstract : Riganti_2005_Br.J.Pharmacol_146_1096
ESTHER : Riganti_2005_Br.J.Pharmacol_146_1096
PubMedSearch : Riganti_2005_Br.J.Pharmacol_146_1096
PubMedID: 16273122

Related information

Citations formats

Riganti L, Matteoni C, Di Angelantonio S, Nistri A, Gaimarri A, Sparatore F, Canu-Boido C, Clementi F, Gotti C (2005)
Long-term exposure to the new nicotinic antagonist 1,2-bisN-cytisinylethane upregulates nicotinic receptor subtypes of SH-SY5Y human neuroblastoma cells
British Journal of Pharmacology 146 :1096

Riganti L, Matteoni C, Di Angelantonio S, Nistri A, Gaimarri A, Sparatore F, Canu-Boido C, Clementi F, Gotti C (2005)
British Journal of Pharmacology 146 :1096